Description

The aging of the population around the world will consequently lead to a rapid increase in the 65-and-over population by 2030, a population that accounts for the highest incidence and prevalence of eye conditions and diseases. This sets the stage for increased research and development activities, speedy market approvals, and higher awareness through education. The industry has been dominated by a few big players, however there are many small players/startups who have interesting ideas. This Research Service is focused on the shift in technologies and materials, regulatory platform, IP strength and funding scenario prevalent in the stent industry.